跳至主要内容
临床试验/KCT0003999
KCT0003999招募中未知

Safety and efficacy of monthly administration of darbepoetin alfa compared to the methoxy polyethylene glycol-epoetin beta in the treatment of anemia associated with chronic kidney disease in non-dialysis patients

Soon Chun Hyang University Hospital Bucheon0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 99(Year)(—)
性别
All

入选标准

  • (1) Age (confirm at screening only): 18-99 years of age; (2) KDOQI CKD stages 4 or 5 using CKD Epidemiology collaboration (CKD-EPI) formula and were not on dialysis; (3) who had Hb 8 to 10 g/dL at baseline; adequate iron status (serum ferritin and transferrin saturation =100 ng/mL and =20%, respectively)

排除标准

  • (1) Active cancer patients; (2) who was diagnosed decompensated liver cirrhosis and heart failure; (3) who had Arrhythmia, Asthma, COPD; adequate iron status (serum ferritin and transferrin saturation =100 ng/mL and =20%, respectively); (4) who have been treated erythropoietin stimulating agents (ESAs) previously; (5) who had history of GI bleeding, hemorrhage by trauma and menorrhagia; (6) pregnent woman

研究者

发起方
Soon Chun Hyang University Hospital Bucheon

相似试验